Integrated Pulmonary Index enabled for Nursing

N/A

Waitlist Available

Led By Aaron Conway, PhD

Research Sponsored by University Health Network, Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from the time between first sedative medication administration to the end of the procedure. estimated duration of procedures is 30 minutes to 120 minutes.

Awards & highlights

No Placebo-Only Group

Summary

This trial tests if using capnography with a smart alert system helps nurses better monitor patients' breathing during sedation. It focuses on patients who might have breathing issues while sedated. The system simplifies data to quickly alert nurses when help is needed.

Eligible Conditions

Nursing
Conscious Sedation
Anesthesia

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from the time between first sedative medication administration to the end of the procedure. estimated duration of procedures is 30 minutes to 120 minutes.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from the time between first sedative medication administration to the end of the procedure. estimated duration of procedures is 30 minutes to 120 minutes.

This trial's timeline: 3 weeks for screening, Varies for treatment, and from the time between first sedative medication administration to the end of the procedure. estimated duration of procedures is 30 minutes to 120 minutes. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of seconds in an alert condition state from the Medtronic Capnostream 35p monitor without an intervention being applied.

Secondary study objectives

Adverse sedation events

Area under the curve of oxygen desaturation

Duration of alert conditions (defined as the total time that an alert condition was active)

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Integrated Pulmonary Index enabledExperimental Treatment1 Intervention

Nurses randomized to the experimental arm will be asked to enable the Integrated Pulmonary Index feature of the Medtronic Capnostream 35p monitor when monitoring sedated patients with capnography.

Group II: Integrated Pulmonary Index disabledActive Control1 Intervention

Nurses randomized to the experimental arm will be asked to disable the Integrated Pulmonary Index feature of the Medtronic Capnostream 35p monitor when monitoring sedated patients with capnography.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Integrated Pulmonary Index

2022

N/A

~410

Do I qualify?Apply below to find out